داروسازی زاگرس فارمد پارس

ددام | Stocks - Tehran Stock Exchange (TSE)

داروهای شیمیایی و گیاهی

Sector:

Market Type:

Status:

Last Price: - 0.00

Close Price: -

	2026/06/22 Fiscal Year 2026/03/2012 Month	2025/06/01 Fiscal Year 2025/03/2012 Month	2024/06/08 Fiscal Year 2024/03/1912 Month
Net Profit to Sales	26.93	25.08	29.47
Gross Profit to Sales	34.63	30.5	35.96
Operating Margin	38.23	34.92	42.2
Gross Profit to Sales	44.84	39.86	47.67
Net Profit to Gross Profit	60.06	62.92	61.81
Return on Assets (ROA)	18.24	16.74	17.38
Return on Capital (%)	93.13	69.05	164.74
Return on Equity (ROE)	46.9	39.18	39.51
Working Capital Return	69.15	66.64	73.67
Fixed Asset Return	120.53	85.56	79.22
Loan Benefit Assessment	2.57	2.34	2.27
Current Ratio	1.46	1.46	1.44
Quick Ratio	1.26	1.4	1.28
Liquidity Ratio	0.01	0.04	0.06
Net Working Capital	3,798,969	2,922,489	2,571,649
Current Assets Ratio	0.84	0.79	0.77
Inventory Turnover	68.86	52.58	69.12
Receivables Collection Period	384.61	381.84	385.17
Inventory to Working Capital	0.43	0.14	0.37
Working Capital Turnover	2.57	2.66	2.5
Fixed Asset Turnover	4.48	3.41	2.69
Total Asset Turnover	0.68	0.67	0.59
Debt Ratio	0.61	0.57	0.56
Debt to Equity	1.57	1.34	1.27
Long-Term Debt to Equity	0.07	0.05	0.04
Current Debt to Equity	1.48	1.27	1.21
Equity Ratio	38.88	42.73	43.99
Debt Coverage Ratio	5.23	8.64	13.17

At a Glance